Lotrimin Af (Clotrimazole) (clotrimazole)

Topical Antifungals Topical Cream (Gram)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Clotrimazole, an imidazole derivative, is a synthetic azole antifungal agent.

Clotrimazole is a broad-spectrum antifungal agent that exerts its antifungal activity by interfering with the biosynthesis of ergosterol, a major component of the fungal cell membrane. As a result, cell membrane permeability is altered, causing loss of potassium and other cellular constituents. Ergosterol also plays a role in directly stimulating the growth of fungal cells.

The combined effects of these actions result in a dose- and time-dependent inhibition of fungal growth.

Clotrimazole is generally considered to be fungistatic, but exhibits fungicidal effects at higher concentrations. In vitro, clotrimazole exhibits fungistatic and fungicidal activity against most strains of Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum, and Microsporum canis, and Candida species including Candida albicans. In general, the in vitro activity of clotrimazole corresponds to that of tolnaftate and griseofulvin against the mycelia of dermatophytes (Trichophyton, Microsporum, and Epidermophyton), and to that of the polyenes (amphotericin B and nystatin) against Candida.

Resistance to clotrimazole has been observed in some Candida isolates, particularly in immunocompromised patients, and has been linked to overexpression of efflux pump genes. Cross resistance can occur among the azole antifungals (e.g., clotrimazole, ketoconazole, miconazole).

Following oral administration of a lozenge containing 10 mg of clotrimazole and dissolution of the lozenge in the mouth (which takes approximately 30 minutes), concentrations of clotrimazole sufficient to inhibit most species of Candida are present in saliva for up to 3 hours. Administration of a 10-mg clotrimazole lozenge every 3 hours reportedly maintains salivary concentrations of clotrimazole greater than the MIC of the drug for most species of Candida. The long-term effective concentration of clotrimazole in saliva appears to be related to slow release of the drug from the oral mucosa to which the drug is apparently bound.

The total amount of clotrimazole absorbed following dissolution in the mouth of a lozenge containing the drug has not been determined to date.

Following topical and vaginal administration, clotrimazole appears to be minimally absorbed. Following application to the skin, the highest concentrations of clotrimazole are present in the stratum corneum; lower drug concentrations occur in the stratum spinosum and the papillary and reticular dermis.

USES: Clotrimazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and other fungal skin infections (candidiasis). This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Clotrimazole is an azole antifungal that works by preventing the growth of fungus.

Generic name: clotrimazole
Pronunciation: (kloe-TRIM-a-zole)
Drug class: Topical Antifungals
Therapeutic class: Dermatological

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Lotrimin Af (Clotrimazole)

Intelligence content is not available yet.

Indications

The following indications are listed for Lotrimin Af (Clotrimazole):

  • Cutaneous Candidiasis
  • Diaper Rash
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Tinea Versicolor

Also known as: Corporeal Ringworm, Cutaneous Candidosis, Cutaneous Moniliasis, Dermatomycosis Pedis, Dhobie Itch, Diaper Dermatitis, Eczema Marginatum, Jock Itch, Pityriasis Versicolor, Tinea Circinata, Tinea Furfuracea, Tinea Glabrosa, Tinea Inguinalis, Tinea Of The Foot.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

*Known hypersensitivity to clotrimazole or other imidazoles or any ingredient in the formulation.

Adverse reactions

Lozenge: nausea, vomiting, unpleasant mouth sensations, and pruritus.

Topical cream or solution: blistering, erythema, edema, pruritus, burning, stinging, peeling, urticaria, and general irritation of skin.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Cutaneous candidiasis
B37.2ICD10CMCandidiasis of skin and nail
Diaper rash
L22ICD10CMDiaper dermatitis
Tinea corporis
B35.4ICD10CMTinea corporis
Tinea cruris
B35.6ICD10CMTinea cruris
Tinea pedis
B35.3ICD10CMTinea pedis
Tinea versicolor
B36.0ICD10CMPityriasis versicolor

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data